Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Omid Behboud Pharmaceutical is a private Iranian pharmaceutical company headquartered in Tehran, specializing in the manufacturing and distribution of generic medicinal products. The company operates a state-of-the-art production facility in the Eshtehard Industrial Town, which is designed to meet international Good Manufacturing Practice (GMP) standards. Its product portfolio includes a wide range of solid dosage forms, such as tablets and capsules, targeting major therapeutic areas including cardiovascular, gastrointestinal, and neurological disorders. Omid Behboud focuses on enhancing national self-sufficiency in healthcare by providing affordable, high-quality alternatives to imported medications. The company actively engages in the formulation development of new generic products to expand its market presence within Iran and the broader Middle East region. Through its commitment to quality control and modern manufacturing technologies, Omid Behboud has established itself as a reliable supplier for the Iranian healthcare system.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Omid Behboud Pharmaceutical.